geekosystem

University of Florida researchers led by Y. Charles Cao and Dr. Chen Liu have developed an artificial nanoparticle complex that was able to reduce hepatitis C virus (HCV) levels in cultured cells and mice by more than 99%. The research team have endearingly called it a nanozyme, so we shall do the same. It's special because it triggers no negative side effects and works like a spy-sniper superthing.